Real-World study confirms Mogamulizumab's effectiveness against rare skin cancer
NCT ID NCT06113081
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 100 adults with cutaneous T-cell lymphoma (a rare type of skin cancer) who had already tried at least one other treatment. Researchers wanted to see how well the drug mogamulizumab works in everyday medical practice, not just in controlled trials. They measured how many patients had their cancer shrink or disappear for at least 4 months. The goal is to understand the drug's real-world benefits and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS T CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica Dermatologia - A.O.U. Policlinico Consorziale
Bari, Italy
-
Clinica Dermatologica - A.O.U. Luigi Vanvitelli
Naples, Italy
-
Clinica di Ematologia - AOU Ospedali Riuniti delle Marche
Ancona, Italy
-
Divisione di Ematologia - IRCCS Policlinico San Matteo
Pavia, Italy
-
Istituto di Ematologia - Policlinico S.Orsola-Malpighi
Bologna, Italy
-
S.C. Dermatologia - IRCCS Policlinico S. Martino
Genova, Italy
-
S.C. Dermatologia U - A.O.U. Città della Salute e della Scienza di Torino
Torino, Italy
-
S.C. Ematologia - ASST Spedali Civili
Brescia, Italy
-
S.C. Ematologia e CTMO - A.O. Brotzu Ospedale Businco
Cagliari, Italy
-
S.C. Ematologia e Terapie Cellulari - IRCCS Policlinico S. Martino
Genova, Italy
-
S.C. Ematologia e Trapianto emopoietico - A.O. S.Giuseppe Moscati
Avellino, Italy
-
U.O. Ematologia - Ospedale Guglielmo da Saliceto
Piacenza, Italy
-
U.O.C. Dermatologia - Ospedale Maggiore Policlinico Fondazione IRCCS Ca' Granda
Milan, Italy
-
U.O.C. Dermatologia . A.O.U. di Padova
Padova, Italy
-
U.O.C. Ematologia - A.O.U. Senese
Siena, Italy
-
U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II
Bari, Italy
-
U.O.C. Ematologia - Policlinico Tor Vergata
Roma, Italy
-
U.O.C. di Ematologia - A.O.U. Policlinico S. Marco
Catania, Italy
-
UOSD Porfirie e Malattie Rare - IRCCS I.F.O. San Gallicano
Roma, Italy
-
Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi
Florence, Italy
-
Verona - AOU Integrata di Verona - U.O. Ematologia
Verona, 37134, Italy